Sana Biotechnology, Inc. (SANA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 2.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -2.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 35.48M | 61.2M | 43.52M | 94.97M | 50.63M | 50.87M | 61.76M | 49.37M | 110.72M | 90.62M | 2.18M | 116.29M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 11.46M | 12.19M | 10.29M | 10.34M | 11.48M | 17.28M | 14.05M | 16.44M | 16.27M | 20.78M | 19.18M | 16.57M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 24.02M | 49.01M | 33.23M | 40.02M | 39.15M | 33.59M | 47.71M | 32.93M | 94.45M | 69.83M | -17M | 99.72M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -37.87M | -61.2M | -43.52M | -94.97M | -50.63M | -50.87M | -61.76M | -49.37M | -110.72M | -90.62M | -2.18M | -116.29M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 25.2% | -20.31% | 29.54% | -92.37% | 54.27% | 43.87% | -2731.77% | 57.54% | -31.73% | -10.8% | 97.47% | -59.51% |
| EBITDA | -35.48M | -58.15M | -40.32M | -92.12M | -46.98M | -45.17M | -57.7M | -45.48M | -106.98M | -79.36M | 2.32M | -111.84M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 24.48% | -28.72% | 30.12% | -102.56% | 56.08% | 43.07% | -2589.39% | 59.34% | -34.22% | -2.27% | 102.82% | -61.84% |
| D&A (Non-Cash Add-back) | 2.39M | 3.05M | 3.19M | 2.86M | 3.65M | 5.69M | 4.06M | 3.9M | 3.75M | 11.26M | 4.5M | 4.45M |
| EBIT | -37.87M | -61.2M | -42.15M | -50.36M | -50.63M | -50.87M | -61.76M | -49.37M | -110.72M | -90.62M | -2.18M | -116.29M |
| Net Interest Income | 951K | -1.57M | 1M | 577K | 992K | 1.66M | 2.58M | 3.2M | 3.03M | 2.73M | 2.86M | 2.37M |
| Interest Income | 951K | -1.57M | 1M | 577K | 992K | 1.66M | 2.58M | 3.2M | 3.03M | 2.73M | 2.86M | 2.37M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -9.34M | 2.37M | 1.36M | 1.18M | 1.24M | 1.8M | 1.84M | -919K | 3.25M | 2.5M | 3.17M | 2.29M |
| Pretax Income | -47.21M | -58.83M | -42.15M | -93.8M | -49.39M | -49.07M | -59.92M | -50.29M | -107.47M | -88.12M | 984K | -114M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -47.21M | -58.83M | -42.15M | -93.8M | -49.39M | -49.07M | -59.92M | -50.29M | -107.47M | -88.12M | 984K | -114M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 4.41% | -19.88% | 29.66% | -86.51% | 54.05% | 44.31% | -6189.84% | 55.88% | -30.87% | -9.54% | 101.16% | -57.32% |
| Net Income (Continuing) | -47.21M | -58.83M | -42.15M | -93.8M | -49.39M | -49.07M | -59.92M | -50.29M | -107.47M | -88.12M | 984K | -114M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.17 | -0.20 | -0.16 | -0.39 | -0.21 | -0.21 | -0.25 | -0.21 | -0.49 | -0.45 | 0.00 | -0.59 |
| EPS Growth % | 19.05% | 4.76% | 36% | -85.71% | 57.14% | 53.33% | - | 64.41% | -13.95% | -7.14% | 101.09% | -51.28% |
| EPS (Basic) | -0.17 | -0.21 | -0.16 | -0.39 | -0.21 | -0.21 | -0.25 | -0.21 | -0.49 | -0.45 | 0.01 | -0.59 |
| Diluted Shares Outstanding | 276.86M | 253.23M | 260.49M | 238.41M | 237.58M | 236.3M | 235.41M | 234.44M | 217.29M | 197.32M | 200.47M | 192.54M |
| Basic Shares Outstanding | 276.86M | 253.23M | 260.49M | 238.41M | 237.58M | 236.3M | 235.41M | 234.44M | 217.29M | 197.32M | 196.98M | 192.54M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |